Nanomedicine, nanotechnology in medicine

Comptes Rendus Physique

Volumn 12, Issue 7, 2011, Pages 620-636

  Boisseau, Patrick ^a   Loubaton, Bertrand ^b  

^a CEA LETI   (France)

^b GE HEALTHCARE   (France)

Author keywords

Diagnostic; Drug delivery; Nanomedicine; Nanotechnology; Regenerative medicine; Theranostic

Indexed keywords

EID: 80052887806     PISSN: 16310705     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crhy.2011.06.001     Document Type: Short Survey

References (26)

1. European Science Foundation, Nanomedicine, an ESF-European Medical Research Councils (EMRC) forward look report, 2005.
2. European Technology Platform on Nanomedicine, Nanotechnology for Health, Vision paper and basis for a strategic research agenda for nanomedicine, EC Publication Office, September 2005.
3. Kreuter J. Nanoparticles - a historical perspective. Int. J. Pharm. 2007, 331(1):1-10.
4. UK Royal Society and Royal Academy of Engineering Report on nanoscience and nanotechnologies: opportunities and uncertainties. http://www.nanotec.org.uk.
5. Commission of the European Communities Communication Towards a European Strategy for Nanotechnology EU, DG Research, Brussels. http://www.cordis.lu/nanotechnology.
6. National Institutes of Health NIH roadmap: nanomedicine NIH, USA. http://nihroadmap.nih.gov.
7. National Institutes of Health - National Cancer Institute Cancer nanotechnology plan: a strategic initiative to transform clinical oncology and basic research through the directed application of nanotechnology NCI, NIH, USA. http://nano.cancer.gov/alliance_cancer_nanotechnology_plan.pdf.
8. Nanotechnology improving healthcare through in vitro biosensors and integrated devices and in-vivo implantable devices and medical imaging, AZoNanotechnology Article, http://www.azonano.com/Details.asp?ArticleID=1701.
9. Christine Vauthier, Patrick Couvreur, Nanotechnologies pour la thérapie et le diagnostic, NM 4010, Les techniques de l?ingénieur, 2008.
10. Debiotech: DebioSTAR™ implantable drug delivery technology for the sustained delivery of pharmaceutical compounds, http://www.debiotech.com/products/drugdd/debiostar.html.
11. Regenerative medicine, NIH fact sheets, September 2006. http://www.nih.gov/about/researchresultsforthepublic/Regen.pdf.
12. Regenerative medicine, NIH fact sheets, September 2006. http://www.nih.gov/about/researchresultsforthepublic/Regen.pdf.
13. ETP Nanomedicine: Nanomedicine, Nanotechnology for Health, Strategic Research Agenda, 2006.
14. Engel Elisabeth, Michiardi Alexandra, Navarro Melba, Lacroix Damien, Planell Josep A. Nanotechnology in regenerative medicine: the materials side. Trends in Biotechnology 2008, 26(1):39-47.
15. Khang D., Carpenter J., Chun Y.W., Pareta R., Webster T.J. Nanotechnology for regenerative medicine. Biomed. Microdevices 2010, 12(4):575-587.
16. Solanki Annirudh, Kim John D., Lee Kim-Bum Nanotechnology for regenerative medicine: nanomaterials for stem cells imaging. Nanomedicine 2008, 3(4):567-578.
17. Marisa Papaluca, Way forward, in: EMA First International Workshop on Nanomedicines, 2010.
18. AFSSAPS, Recommendations for toxicological evaluation of nanoparticle medicinal products, 2009.
19. Culliton Barbara J. Is special FDA regulation of nanomedicine needed? A conversation with Norris E. Alderson. Health Affairs 2008, 27(4).
20. Carlos Pena, A FDA perspective on nanomedicine, current initiatives in the US, in: EMA First International Workshop on Nanomedicine, 2010.
21. Global Industry Analysts Inc., Nanomedicine: a global strategic business report, 2009.
22. BCC Research, Nanotechnology in medical applications: the global market, 2010.
23. Commission particulière du débat public nanotechnologies, Debat public sur les nanotechnologies, http://www.debatpublic-nano.org/.
24. NanoInnov: un plan en faveur des nanotechnologies, Dossier de presse, Ministère de l'enseignement Supérieur et de la Recherche, 5 mai 2009. http://www.enseignementsup-recherche.gouv.fr/cid25281/nano-innov-un-plan-en-faveur-des-nanotechnologies.html.
25. Biotechnologies France: Base de données nationale des biotechnologies, http://www.biotechnologiefrance.org/.
26. Beat Loeffler, Patrick Hunzicker, CLINAM, Private communication, 2010.